Defunct Company
Total Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
468
NCT00063778
Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2003
Completion: Jul 31, 2005
NCT00097838
Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults
Start: Oct 31, 2004
Completion: Sep 30, 2009
NCT00439803
A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV)
Start: Apr 30, 2007
Completion: Jul 31, 2008
NCT00440362
A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza
Phase: Phase 1/2
Completion: Sep 30, 2007
NCT00529984
A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies
Start: Sep 30, 2007
Completion: May 31, 2010
NCT00706732
A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza
Start: Jun 30, 2008
Completion: Mar 31, 2009
NCT01890213
Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer
Role: Collaborator
Start: Nov 30, 2013
Completion: Jul 31, 2019